Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
08/2003
08/27/2003EP1337649A1 Nucleotide sequences which code for the mtra and mtrb gene
08/27/2003EP1337648A2 Novel cyclodextrin glucanotransferase (cgtase), obtained from i bacillus agaradherens /i (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase
08/27/2003EP1337647A2 Helicobacter cysteine rich protein a (hcpa) and uses thereof
08/27/2003EP1337646A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
08/27/2003EP1337630A2 Modified arginine deiminase
08/27/2003EP1337629A1 Dipeptidyl peptidases
08/27/2003EP1337628A1 Production process and composition of an enzymatic preparation, and its use for the treatment of domestic and industrial effluents of high fat, protein and/or carbohydrate content
08/27/2003EP1337576A2 Reduced byproduct high solids polyamine-epihalohydrin compositions
08/27/2003EP1337550A2 Hepatitis c tripeptide inhibitors
08/27/2003EP1337548A2 Anti-angiogenic polypeptides
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337259A2 Methylenetetrahydrofolate reductase inhibitors and use thereof
08/27/2003EP1181046B1 10-formyltetrahydrofolate dehydrogenase as therapeutical agent
08/27/2003EP1140938B1 High affinity inhibitors for target validation and uses thereof
08/27/2003EP0871712B1 Transglutaminases from oomycetes
08/27/2003EP0832186B1 Replacement therapy for dental caries
08/27/2003EP0766734B1 method of stabilizing molecules which are sensitive to hydrolysis
08/27/2003EP0667910B1 A bacillus promoter derived from a variant of a bacillus licheniformis alpha-amylase promoter
08/27/2003CN1439054A Changing fine chemical content in organisms by genetically modifying shikimate pathway
08/27/2003CN1439017A Novel compounds
08/27/2003CN1438315A Beta-lactamase/amino-glucosidic passive zyme interfused gene, its expressed products and composition thereof and use
08/27/2003CN1119418C D-amino acid oxidase of red telioporeae
08/27/2003CN1119414C Mutational 2,5 diketo-D-gluconic acid reductase and its genetic engineering expression
08/27/2003CN1119405C Improved-solubility enzyme granulate
08/26/2003US6610913 Rice plants transformed to provide a PCK-type C4 cycle and methods of making
08/26/2003US6610908 Manipulation of lignin composition in plants using a tissue-specific promoter
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610843 Modified starch from plants, plants synthesizing the same, as well as process for their production
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610672 Carbohydrate inhibits degradation; storage stability; heat resistance
08/26/2003US6610663 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
08/26/2003US6610545 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
08/26/2003US6610541 Recombinant, active caspases and uses thereof
08/26/2003US6610537 Human kinases and polynucleotides encoding the same
08/26/2003US6610536 Nucleic acids and polypeptides
08/26/2003US6610534 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases
08/26/2003US6610527 The taxadiene synthase gene of Pacific yew has been cloned and its nucleic acid and polypeptide sequence is presented. Truncation or removal of the transit peptide increases expression of the cloned taxadiene synthase gene expression in
08/26/2003US6610525 Motor proteins and methods for their use
08/26/2003US6610524 Nucleotide sequences coding enzymatic polypeptide for use in cosmetics, pharmacology and food processing
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610522 Cloned genes encoding reverse transcriptase lacking RNase H activity
08/26/2003US6610521 Isolated nucleic acid fragment encoding a protein involved in phenylpropanoid metabolism. The invention also relates to the construction of a chimeric gene encoding all or a portion of the protein involved in phenylpropanoid metabolism,
08/26/2003US6610520 Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
08/26/2003US6610519 Solid phytase composition stabilized with lactic acid provided by corn steep liquor
08/26/2003US6610517 Compartmentalization of recombinant polypeptides in host cells
08/26/2003US6610516 A glycoprotein is produced by a process comprising culturing mammalian host cells expressing nucleic acid encoding a glycoprotein in the presence of (a) a factor that modifies growth state in a cell culture, (b) a divalent metal cation or
08/26/2003US6610514 Yeast vector and method of producing proteins using the same
08/26/2003US6610505 Oncoprotein protein kinase
08/26/2003US6610497 Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
08/26/2003US6610492 The present invention is directed to novel base-modified nucleotides and methods for their use in the preparation and cleavage of modified polynucleotides.
08/26/2003US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function
08/26/2003US6610479 Enzymes or catalytic fragments thereof reversibly inactivated by attachment to an immobilizing moiety which may comprise a magnetic particle are activated by release from the immobilizing moiety. The enzyme or fragment may be in the form
08/26/2003US6610475 Kits for processing biological specimens for nucleic acid hybridization assays, target amplification reactions and similar uses
08/26/2003US6610474 Cells for detection of influenza and parainfluenza viruses
08/26/2003US6610334 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins
08/26/2003US6610332 Antiprotozoa agents; plant extracts
08/26/2003US6610299 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates for treating cancers.
08/26/2003US6610290 Transferring preferential nucleotide sequences to cells; obtain cells, incubate with expression vector, transform cells, recover transformed cells
08/26/2003US6610289 Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
08/25/2003CA2419773A1 Matrix metalloproteinase and tumor necrosis factor inhibitors
08/21/2003WO2003068991A1 Polymerase compositions
08/21/2003WO2003068975A1 ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION
08/21/2003WO2003068974A2 YkuR POLYNUCLEOTIDES AND POLYPEPTIDES
08/21/2003WO2003068963A1 Deoxyribozymes
08/21/2003WO2003068960A1 Transposon being functional in mammals
08/21/2003WO2003068955A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
08/21/2003WO2003068954A2 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003WO2003068951A1 Ralstonia ahl-acylase gene
08/21/2003WO2003068950A1 Tissue-type plasminogen activator (t-pa) inhibitors with a therapeutic capacity
08/21/2003WO2003068949A1 Treatment of muscle damage
08/21/2003WO2003068948A1 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
08/21/2003WO2003068945A2 Detection of molecular interaction by reactivation of an auto-inhibited responder (rair)
08/21/2003WO2003068932A2 Method for crystallizing human gsk3 and novel crystal structure thereof
08/21/2003WO2003068926A2 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
08/21/2003WO2003068917A2 Functionalization of carotenoid compounds
08/21/2003WO2003068914A2 Solution structure of rip dd and uses therof
08/21/2003WO2003068911A2 Citrus tristeza virus resistance genes and methods of use
08/21/2003WO2003068910A2 Glycosidases, nucleic acids encoding them and methods of making and using them
08/21/2003WO2003068909A2 Transaminases, nucleic acids encoding them and methods of making and using them
08/21/2003WO2003068907A2 Method for the generation of proteins with new enzymatic function
08/21/2003WO2003068168A2 Helical peptidomimetics and use b-amyloid-associated diseases
08/21/2003WO2003068167A2 Novel treatment for pathologies associated with oxidative damage
08/21/2003WO2003068153A2 CARDIAC-SPECIFIC 11β HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
08/21/2003WO2003055904A3 Peptidyl-trna hydrolase from pseudomonas aeruginosa
08/21/2003WO2003048352A3 Histone h3 methyltransferase polypeptide
08/21/2003WO2003029451A3 Histone deacetylase 9
08/21/2003WO2003027245B1 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE
08/21/2003WO2003027243A3 Phytate polynucleotides and methods of use
08/21/2003WO2003025156A3 Methods and apparatuses for purification
08/21/2003WO2003020914A3 Protein phosphatase stress-related polypeptides and methods of use in plants
08/21/2003WO2003016474A3 Methods and compositions for use in selectively producing a protein in telomerase expressing cells
08/21/2003WO2003011220A3 Animal model for fatty acid amide-related neurobehaviors
08/21/2003WO2003004665A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
08/21/2003WO2003004006A8 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
08/21/2003WO2003002719A3 Isoform of castor oleate hydroxylase
08/21/2003WO2002092800A3 Crystal structure of 2c-methyl-d-erythritol 2,4-cyclodiphosphate synthase
08/21/2003WO2002089739A3 Peptide deformylase activated prodrugs
08/21/2003WO2002083182A3 The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification
08/21/2003WO2002077198A8 Methods of modulating angiogenesis
1 ... 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 ... 1416